JPRN-UMIN000005061
Completed
Phase 1
A phase I study of stereotactic body radiotherapy with real-time tumor tracking using CyberKnife and Monte Carlo algorithm for lung tumors. - A phase I study of stereotactic body radiotherapy with real-time tumor tracking using CyberKnife and Monte Carlo algorithm for lung tumors.
Department of Radiology, Nagoya City University Graduate School of Medical Sciences0 sites35 target enrollmentFebruary 18, 2011
Conditionslung tumor
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- lung tumor
- Sponsor
- Department of Radiology, Nagoya City University Graduate School of Medical Sciences
- Enrollment
- 35
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.active infection needed therapy 2\.fever of 38\.0 degrees centigrade or higher 3\.pregnancy 4\.psychiatric disorder 5\.steroid administration 6\.Patients who are considered to be inappropriate for this study by physicians
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
A phase I trial of stereotactic body radiotherapy for limited hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000003090Division of Radiation Oncology and division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan12
Recruiting
Phase 1
Phase I study of postoperative stereotactic body radiotherapy for prostate cancerJPRN-jRCT1030220062Yamashita Hideomi36
Completed
Not Applicable
Phase II trial of stereotactic body radiotherapy for non-spine bone metastases.non-spine bone metastasesJPRN-UMIN000033132Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital35
Completed
Phase 1
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate CancerMale Breast CarcinomaProstate AdenocarcinomaRecurrent Breast CarcinomaRecurrent Non-Small Cell Lung CarcinomaRecurrent Prostate CarcinomaStage IV Breast CancerStage IV Non-Small Cell Lung CancerStage IV Prostate CancerNCT02206334NRG Oncology42
Active, not recruiting
Phase 1
Phase I trial of stereotactic body radiotherapy with concurrent pembrolizumab in metastatic urothelial cancer.Metastatic urothelial cancerTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-001263-37-BEZ Gent20